An app that tracks cigarette cravings and moods, one that guides patients through proper inhaler use, and 3 other top COPD apps for both patients and physicians.
Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPD
In a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.
Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.
Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns
Participants with AF who used wearable devices reported higher anxiety levels and increased health care usage than nonusers, according to a new study.
FDA Approves Ensifentrine for Maintenance Treatment of COPD in Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
SECURE-T2D: Automated Insulin Delivery System Reduced A1c in Adults with Type 2 Diabetes
ADA 2024. Adults started on the Omnipod 5 AID system had an A1c reduction from 8.2% at baseline to 7.4% at 13 weeks, researchers report.
CGM Data May Enhance Prediction of Risk for Type 1 Diabetes in Those with Early Stage Disease
ADA 2024. The risk of progression to stage 3 type 1 diabetes may be better predicted using a combination of patient and CGM data, a new study suggests.